Nifty
:
19674.25
Sensex
:
66009.15
-68.10 (-0.34%)
-221.09 (-0.33%)
Nifty
Sensex
:
:
19674.25
66009.15
-68.10 (-0.34%)
-221.09 (-0.33%)

Ambalal Sarabhai Enterprises Ltd.

Pharmaceuticals & Drugs

Rating :
53/99

BSE: 500009 | NSE: AMBASARABH

NSE BSE
36.63
22-Sep-2023
  • Open
  • High
  • Low
  • Previous Close
  •  35.63
  •  36.75
  •  35.00
  •  35.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  461
  •  89.65
  •  39.38
  •  20.04

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 280.71
  • 60.60
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 278.08
  • N/A
  • 2.22

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.77%
  • 1.78%
  • 61.54%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.91%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.98
  • 9.50
  • 13.80

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -10.47
  • -23.23
  • -6.67

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 112.88
  • 45.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.21
  • 13.08
  • 7.81

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.61
  • 2.94
  • 2.56

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.24
  • 7.68
  • 6.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Net Sales
36.10
43.65
-17.30%
44.44
54.43
-18.35%
35.36
43.10
-17.96%
46.84
56.49
-17.08%
Expenses
39.09
41.66
-6.17%
41.09
53.05
-22.54%
33.46
36.75
-8.95%
45.49
46.61
-2.40%
EBITDA
-2.99
1.98
-
3.35
1.38
142.75%
1.90
6.34
-70.03%
1.34
9.88
-86.44%
EBIDTM
-8.29%
4.55%
7.53%
2.54%
5.36%
14.72%
2.87%
17.50%
Other Income
1.37
2.69
-49.07%
4.36
8.54
-48.95%
3.06
0.65
370.77%
2.38
2.10
13.33%
Interest
0.95
0.43
120.93%
0.99
0.45
120.00%
0.56
0.33
69.70%
0.45
0.34
32.35%
Depreciation
1.05
0.60
75.00%
0.92
0.62
48.39%
0.62
0.58
6.90%
0.62
0.56
10.71%
PBT
-3.63
3.64
-
5.80
8.85
-34.46%
3.79
6.09
-37.77%
2.64
10.97
-75.93%
Tax
0.27
0.82
-67.07%
1.44
1.22
18.03%
0.45
2.19
-79.45%
1.02
1.42
-28.17%
PAT
-3.90
2.82
-
4.36
7.63
-42.86%
3.34
3.89
-14.14%
1.62
9.56
-83.05%
PATM
-10.80%
6.46%
9.81%
14.01%
9.45%
9.03%
3.47%
16.92%
EPS
-0.64
0.21
-
0.72
0.99
-27.27%
0.39
0.46
-15.22%
0.13
1.24
-89.52%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
162.74
196.75
163.64
133.50
151.88
125.00
133.88
131.98
124.50
104.65
100.24
Net Sales Growth
-17.67%
20.23%
22.58%
-12.10%
21.50%
-6.63%
1.44%
6.01%
18.97%
4.40%
 
Cost Of Goods Sold
98.65
114.71
99.97
79.34
89.52
70.20
76.92
72.88
72.73
58.10
54.18
Gross Profit
64.09
82.04
63.68
54.16
62.36
54.81
56.95
59.11
51.76
46.55
46.07
GP Margin
39.38%
41.70%
38.91%
40.57%
41.06%
43.85%
42.54%
44.79%
41.57%
44.48%
45.96%
Total Expenditure
159.13
171.51
165.18
135.40
145.99
136.74
144.95
144.67
128.83
113.27
110.61
Power & Fuel Cost
-
3.64
2.86
2.71
3.22
2.84
2.68
3.67
2.80
2.36
2.97
% Of Sales
-
1.85%
1.75%
2.03%
2.12%
2.27%
2.00%
2.78%
2.25%
2.26%
2.96%
Employee Cost
-
25.27
28.17
27.06
26.02
26.67
28.71
31.29
28.47
27.39
30.28
% Of Sales
-
12.84%
17.21%
20.27%
17.13%
21.34%
21.44%
23.71%
22.87%
26.17%
30.21%
Manufacturing Exp.
-
6.17
5.74
4.07
5.09
5.18
5.43
7.13
5.53
6.00
5.12
% Of Sales
-
3.14%
3.51%
3.05%
3.35%
4.14%
4.06%
5.40%
4.44%
5.73%
5.11%
General & Admin Exp.
-
11.31
10.79
11.94
10.92
24.21
12.52
13.39
10.03
9.56
8.93
% Of Sales
-
5.75%
6.59%
8.94%
7.19%
19.37%
9.35%
10.15%
8.06%
9.14%
8.91%
Selling & Distn. Exp.
-
7.79
10.27
7.03
7.92
4.86
6.53
6.42
6.08
4.66
4.11
% Of Sales
-
3.96%
6.28%
5.27%
5.21%
3.89%
4.88%
4.86%
4.88%
4.45%
4.10%
Miscellaneous Exp.
-
2.62
7.38
3.26
3.30
2.79
12.16
9.90
3.19
5.18
4.11
% Of Sales
-
1.33%
4.51%
2.44%
2.17%
2.23%
9.08%
7.50%
2.56%
4.95%
5.01%
EBITDA
3.60
25.24
-1.54
-1.90
5.89
-11.74
-11.07
-12.69
-4.33
-8.62
-10.37
EBITDA Margin
2.21%
12.83%
-0.94%
-1.42%
3.88%
-9.39%
-8.27%
-9.62%
-3.48%
-8.24%
-10.35%
Other Income
11.17
42.02
30.58
24.39
5.47
25.04
6.22
95.08
12.99
3.01
16.41
Interest
2.95
2.04
3.20
3.61
3.29
3.41
4.77
4.10
9.83
10.93
8.52
Depreciation
3.21
2.32
2.41
2.57
2.10
2.12
4.27
16.54
4.81
3.01
14.02
PBT
8.60
62.89
23.43
16.31
5.97
7.77
-13.90
61.74
-5.98
-19.55
-16.50
Tax
3.18
6.98
3.19
0.88
3.97
6.69
4.61
13.61
0.69
0.66
1.48
Tax Rate
36.98%
14.61%
13.62%
5.40%
66.50%
86.10%
-33.17%
22.04%
-11.54%
-3.38%
-8.97%
PAT
5.42
47.22
29.35
15.44
2.00
1.08
-18.51
48.14
-6.67
-20.21
-17.97
PAT before Minority Interest
5.42
47.22
29.35
15.44
2.00
1.08
-18.51
48.14
-6.67
-20.21
-17.97
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.33%
24.00%
17.94%
11.57%
1.32%
0.86%
-13.83%
36.48%
-5.36%
-19.31%
-17.93%
PAT Growth
-77.32%
60.89%
90.09%
672.00%
85.19%
-
-
-
-
-
 
EPS
0.71
6.16
3.83
2.02
0.26
0.14
-2.42
6.28
-0.87
-2.64
-2.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
119.87
73.90
44.77
30.62
26.52
25.17
38.73
-9.40
-2.16
17.94
Share Capital
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
Total Reserves
43.23
-2.74
-31.87
-46.01
-50.12
-51.46
-37.90
-86.04
-78.79
-58.69
Non-Current Liabilities
4.73
5.35
4.81
8.90
11.39
5.83
12.70
15.43
59.01
17.14
Secured Loans
2.73
5.17
4.54
8.76
11.12
5.11
5.72
5.76
3.20
4.09
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.00
0.00
Long Term Provisions
1.82
2.25
3.37
3.80
4.38
5.53
6.75
9.85
55.84
12.33
Current Liabilities
105.47
128.54
133.47
171.32
155.44
124.43
152.51
162.77
154.55
175.34
Trade Payables
47.30
50.40
40.02
46.83
39.76
29.14
26.93
27.54
28.33
21.13
Other Current Liabilities
33.27
53.52
64.73
91.29
80.43
50.08
56.70
91.85
86.32
73.61
Short Term Borrowings
21.87
20.75
24.80
28.76
30.34
35.33
39.50
38.92
36.67
33.45
Short Term Provisions
3.03
3.86
3.92
4.44
4.91
9.88
29.38
4.46
3.22
47.15
Total Liabilities
230.06
207.78
183.04
210.83
193.35
155.43
203.94
168.80
211.40
210.42
Net Block
58.33
56.86
57.46
57.65
59.16
72.25
71.76
90.78
94.32
98.39
Gross Block
71.75
68.54
68.24
65.91
65.36
76.34
138.02
153.64
152.39
154.51
Accumulated Depreciation
13.41
11.68
10.78
8.26
6.20
4.09
66.26
62.86
58.07
56.11
Non Current Assets
109.86
87.19
79.06
94.58
79.79
82.18
91.54
100.43
143.97
105.56
Capital Work in Progress
11.63
0.77
0.41
24.06
13.69
3.44
8.97
0.83
0.21
0.10
Non Current Investment
32.62
27.30
18.14
9.36
5.37
4.83
8.10
0.62
0.78
1.30
Long Term Loans & Adv.
3.10
1.48
2.11
1.98
1.48
1.50
1.95
7.73
48.44
2.79
Other Non Current Assets
4.17
0.78
0.94
1.53
0.10
0.17
0.77
0.48
0.22
2.98
Current Assets
120.19
120.59
103.98
116.26
113.55
73.25
112.40
68.37
67.43
104.85
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.27
0.15
0.00
Inventories
15.14
15.97
16.45
14.98
14.39
13.81
14.41
17.10
15.13
13.72
Sundry Debtors
28.06
38.81
28.80
34.69
34.13
28.95
30.11
25.29
27.18
27.84
Cash & Bank
28.25
31.38
21.53
23.26
22.07
16.71
16.41
13.85
12.28
7.16
Other Current Assets
48.74
11.77
11.25
15.94
42.95
13.77
51.47
11.86
12.68
56.14
Short Term Loans & Adv.
29.31
22.65
25.95
27.39
17.66
11.38
37.98
11.41
11.18
54.83
Net Current Assets
14.72
-7.95
-29.49
-55.06
-41.89
-51.18
-40.11
-94.40
-87.12
-70.48
Total Assets
230.05
207.78
183.04
210.84
193.34
155.43
203.94
168.80
211.40
210.41

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
11.47
-2.30
-6.88
18.80
-7.39
5.40
-74.99
-8.32
11.02
-3.26
PBT
54.19
32.54
14.94
8.21
7.96
-13.62
61.74
-5.98
-19.55
-16.50
Adjustment
-19.82
-24.92
-13.26
1.79
-11.90
17.83
-67.13
2.50
14.47
6.76
Changes in Working Capital
-19.35
-7.96
-6.07
16.64
16.46
2.77
-64.49
-0.39
17.76
8.26
Cash after chg. in Working capital
15.02
-0.34
-4.40
26.65
12.53
6.98
-69.88
-3.88
12.67
-1.48
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.55
-1.96
-2.48
-7.84
-19.93
-1.58
-5.12
-4.44
-1.66
-1.78
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
5.08
10.09
16.89
-9.25
17.58
-3.31
80.06
9.80
-0.89
-0.28
Net Fixed Assets
1.12
0.13
-0.23
-0.06
1.03
56.92
20.63
0.40
0.84
2.06
Net Investments
9.38
29.85
2.59
-0.09
8.92
6.72
-26.62
-0.13
1.83
0.50
Others
-5.42
-19.89
14.53
-9.10
7.63
-66.95
86.05
9.53
-3.56
-2.84
Cash from Financing Activity
-19.19
-5.84
-14.22
-6.07
-2.09
-6.26
-3.44
-0.61
-8.39
2.75
Net Cash Inflow / Outflow
-2.64
1.95
-4.21
3.49
8.10
-4.17
1.62
0.87
1.74
-0.79
Opening Cash & Equivalents
14.74
12.79
17.00
13.51
5.41
9.58
8.40
7.53
5.79
6.58
Closing Cash & Equivalent
12.10
14.74
12.79
17.00
13.51
5.41
10.03
8.40
7.53
5.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
15.64
9.64
5.84
4.00
3.46
3.28
5.05
-1.23
-0.28
2.34
ROA
21.57%
15.02%
7.84%
0.99%
0.62%
-10.30%
25.83%
-3.51%
-9.58%
-8.29%
ROE
48.74%
49.47%
40.95%
7.01%
4.20%
-57.92%
328.25%
0.00%
-256.13%
-66.09%
ROCE
45.53%
40.28%
27.14%
13.17%
16.34%
-11.94%
107.14%
10.08%
-17.91%
-12.98%
Fixed Asset Turnover
2.88
2.44
2.06
2.34
1.77
1.27
0.93
0.83
0.70
0.66
Receivable days
60.46
73.84
83.82
81.74
91.65
79.06
74.77
75.18
93.62
88.35
Inventory Days
28.13
35.41
41.50
34.90
40.98
37.78
42.53
46.19
49.09
46.00
Payable days
155.45
165.09
199.78
117.80
109.36
81.80
71.83
85.02
86.62
87.50
Cash Conversion Cycle
-66.86
-55.84
-74.47
-1.16
23.27
35.04
45.47
36.35
56.09
46.86
Total Debt/Equity
0.21
0.37
0.70
1.31
1.63
1.67
1.22
-4.94
-19.21
2.17
Interest Cover
27.54
11.17
5.52
2.81
3.28
-1.91
16.06
0.39
-0.79
-0.94

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Ambalal Sarabhai Ent - Quarterly Results
    10th Aug 2023, 17:06 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.